A Multicenter, Randomized, Single-blind, Active-controlled, Phase III Clinical Study to Compare the Efficacy and Safety of QL1012(Recombinant Human Follicle-stimulating Hormone) and Gonal-f in Women Undergoing Controlled Ovarian Hyperstimulation for Assisted Reproductive Treatment
Latest Information Update: 21 Mar 2023
At a glance
- Drugs QL 1012 (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Registrational; Therapeutic Use
- Sponsors Qilu Pharmaceutical
- 01 Mar 2023 Results published in the Reproductive Biomedicine Online
- 15 Dec 2021 New trial record